Jan 11, 2022 / 09:30PM GMT
Anupam Rama - JPMorgan Chase & Co, Research Division - VP and Analyst
Welcome, everyone, to the 40th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm the senior biotech analysts here at JPMorgan. I'm joined by Malcolm Kuno, Priyankar Grover and KalodSmith from the team, our next presenting company is Cytokinetics and presenting on behalf of the company, we have CEO, Robert Blum. I wanted to remind attendees of this session that there is an ask a question feature in the portal, if you'd like me to ask a question on your behalf, to submit the question, and I'm happy to do that in the Q&A.
With that, Robert, take you away.
Robert I. Blum - Cytokinetics, Incorporated - CEO, President & Director
Thank you, Anupam, and thank you to the organizers for having us present the company today. I'll be sharing a presentation on Cytokinetics. And then ultimately, our management team will be available also for Q&A. Cytokinetics is a company focused to muscle biology, and as such, we're mining this space for new medicines as would
Cytokinetics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot